{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:49:35Z","timestamp":1790210975612,"version":"4.1.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071735"],"award-info":[{"award-number":["82071735"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12265-025-10678-z","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T18:22:19Z","timestamp":1755541339000},"page":"1336-1352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Reprogramming of Mitochondrial and Cellular Energy Metabolism in Fibroblasts and Cardiomyocytes: Mechanisms and Therapeutic Strategies in Cardiac Fibrosis"],"prefix":"10.1007","volume":"18","author":[{"given":"Junyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6479-3636","authenticated-orcid":false,"given":"Zhongxiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"10678_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","volume":"117","author":"NG Frangogiannis","year":"2021","unstructured":"Frangogiannis NG. Cardiac fibrosis. Cardiovasc Res. 2021;117:1450\u201388.","journal-title":"Cardiovasc Res"},{"key":"10678_CR2","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jacc.2018.02.021","volume":"71","author":"A Gonz\u00e1lez","year":"2018","unstructured":"Gonz\u00e1lez A, Schelbert EB, D\u00edez J, Butler J. Myocardial interstitial fibrosis in heart failure: biological and translational perspectives. J Am Coll Cardiol. 2018;71:1696\u2013706.","journal-title":"J Am Coll Cardiol"},{"key":"10678_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/13543784.2021.1868432","volume":"30","author":"R Spoladore","year":"2021","unstructured":"Spoladore R, Falasconi G, Fiore G, Di Maio S, Preda A, Slavich M, Margonato A, Fragasso G. Cardiac fibrosis: emerging agents in preclinical and clinical development. Expert Opin Investig Drugs. 2021;30:153\u201366.","journal-title":"Expert Opin Investig Drugs"},{"key":"10678_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41588-023-01371-5","volume":"55","author":"V Nauffal","year":"2023","unstructured":"Nauffal V, Di Achille P, Klarqvist MDR, Cunningham JW, Hill MC, Pirruccello JP, Weng L-C, Morrill VN, Choi SH, Khurshid S, Friedman SF, Nekoui M, Roselli C, Ng K, Philippakis AA, Batra P, Ellinor PT, Lubitz SA. Genetics of myocardial interstitial fibrosis in the human heart and association with disease. Nat Genet. 2023;55:777\u201386.","journal-title":"Nat Genet"},{"key":"10678_CR5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrcardio.2017.57","volume":"14","author":"MD Tallquist","year":"2017","unstructured":"Tallquist MD, Molkentin JD. Redefining the identity of cardiac fibroblasts. Nat Rev Cardiol. 2017;14:484\u201391.","journal-title":"Nat Rev Cardiol"},{"key":"10678_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","volume":"15","author":"PM-K Tang","year":"2019","unstructured":"Tang PM-K, Nikolic-Paterson DJ, Lan H-Y. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15:144\u201358.","journal-title":"Nat Rev Nephrol"},{"key":"10678_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/cvr\/cvae021","volume":"120","author":"IF Hall","year":"2024","unstructured":"Hall IF, Kishta F, Xu Y, Baker AH, Kovacic JC. Endothelial to mesenchymal transition: at the axis of cardiovascular health and disease. Cardiovasc Res. 2024;120:223\u201336.","journal-title":"Cardiovasc Res"},{"key":"10678_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","volume":"573","author":"H Aghajanian","year":"2019","unstructured":"Aghajanian H, Kimura T, Rurik JG, Hancock AS, Leibowitz MS, Li L, Scholler J, Monslow J, Lo A, Han W, Wang T, Bedi K, Morley MP, Linares Saldana RA, Bolar NA, McDaid K, Assenmacher C-A, Smith CL, Wirth D, June CH, Margulies KB, Jain R, Pur\u00e9 E, Albelda SM, Epstein JA. Targeting cardiac fibrosis with engineered T cells. Nature. 2019;573:430\u20133.","journal-title":"Nature"},{"key":"10678_CR9","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.111.052399","volume":"124","author":"W Zhang","year":"2011","unstructured":"Zhang W, Chancey AL, Tzeng H-P, Zhou Z, Lavine KJ, Gao F, Sivasubramanian N, Barger PM, Mann DL. The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions. Circulation. 2011;124:2106\u201316.","journal-title":"Circulation"},{"key":"10678_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","volume":"65","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis NG. Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med. 2019;65:70\u201399.","journal-title":"Mol Aspects Med"},{"key":"10678_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.actbio.2019.03.017","volume":"89","author":"CO Heras-Bautista","year":"2019","unstructured":"Heras-Bautista CO, Mikhael N, Lam J, Shinde V, Katsen-Globa A, Dieluweit S, Molcanyi M, Uvarov V, J\u00fctten P, Sahito RGA, Mederos-Henry F, Piechot A, Brockmeier K, Hescheler J, Sachinidis A, Pfannkuche K. Cardiomyocytes facing fibrotic conditions re-express extracellular matrix transcripts. Acta Biomater. 2019;89:180\u201392.","journal-title":"Acta Biomater"},{"key":"10678_CR12","first-page":"51","volume":"10","author":"WP Lafuse","year":"2020","unstructured":"Lafuse WP, Wozniak DJ, Rajaram MVS. Role of cardiac macrophages on cardiac inflammation. Fibrosis Tissue Repair Cells. 2020;10:51.","journal-title":"Fibrosis Tissue Repair Cells"},{"key":"10678_CR13","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm1613","volume":"13","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007;13:952\u201361.","journal-title":"Nat Med"},{"key":"10678_CR14","doi-asserted-by":"publisher","first-page":"H1233","DOI":"10.1152\/ajpheart.00328.2014","volume":"307","author":"A Saxena","year":"2014","unstructured":"Saxena A, Dobaczewski M, Rai V, Haque Z, Chen W, Li N, Frangogiannis NG. Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function. Am J Physiol Heart Circ Physiol. 2014;307:H1233-1242.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10678_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3389\/fimmu.2019.00580","volume":"10","author":"SA Legere","year":"2019","unstructured":"Legere SA, Haidl ID, L\u00e9gar\u00e9 J-F, Marshall JS. Mast cells in cardiac fibrosis: new insights suggest opportunities for intervention. Front Immunol. 2019;10:580.","journal-title":"Front Immunol"},{"key":"10678_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero E, Maack C. Metabolic remodelling in heart failure. Nat Rev Cardiol. 2018;15:457\u201370.","journal-title":"Nat Rev Cardiol"},{"key":"10678_CR17","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED. Cardiac energy metabolism in heart failure. Circ Res. 2021;128:1487\u2013513.","journal-title":"Circ Res"},{"key":"10678_CR18","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tem.2021.05.003","volume":"32","author":"J Henderson","year":"2021","unstructured":"Henderson J, O\u2019Reilly S. The emerging role of metabolism in fibrosis. Trends Endocrinol Metab. 2021;32:639\u201353.","journal-title":"Trends Endocrinol Metab"},{"key":"10678_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","volume":"127","author":"AA Gibb","year":"2020","unstructured":"Gibb AA, Lazaropoulos MP, Elrod JW. Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation. Circ Res. 2020;127:427\u201347.","journal-title":"Circ Res"},{"key":"10678_CR20","doi-asserted-by":"publisher","first-page":"eaav3048","DOI":"10.1126\/scisignal.aav3048","volume":"12","author":"B Selvarajah","year":"2019","unstructured":"Selvarajah B, Azuelos I, Plat\u00e9 M, Guillotin D, Forty EJ, Contento G, Woodcock HV, Redding M, Taylor A, Brunori G, Durrenberger PF, Ronzoni R, Blanchard AD, Mercer PF, Anastasiou D, Chambers RC. mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-\u03b21-induced collagen biosynthesis. Sci Signal. 2019;12:eaav3048.","journal-title":"Sci Signal"},{"key":"10678_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1161\/CIRCRESAHA.119.315483","volume":"126","author":"J Ritterhoff","year":"2020","unstructured":"Ritterhoff J, Young S, Villet O, Shao D, Neto FC, Bettcher LF, Hsu Y-WA, Kolwicz SC, Raftery D, Tian R. Metabolic remodeling promotes cardiac hypertrophy by directing glucose to aspartate biosynthesis. Circ Res. 2020;126:182\u201396.","journal-title":"Circ Res"},{"key":"10678_CR22","doi-asserted-by":"publisher","first-page":"H2889","DOI":"10.1152\/ajpheart.91501.2007","volume":"294","author":"Q Wang","year":"2008","unstructured":"Wang Q, Donthi RV, Wang J, Lange AJ, Watson LJ, Jones SP, Epstein PN. Cardiac phosphatase-deficient 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase increases glycolysis, hypertrophy, and myocyte resistance to hypoxia. Am J Physiol Heart Circ Physiol. 2008;294:H2889-2897.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10678_CR23","doi-asserted-by":"publisher","first-page":"102907","DOI":"10.1016\/j.redox.2023.102907","volume":"67","author":"G Tian","year":"2023","unstructured":"Tian G, Zhou J, Quan Y, Kong Q, Li J, Xin Y, Wu W, Tang X, Liu X. Voltage-dependent anion channel 1 (VDAC1) overexpression alleviates cardiac fibroblast activation in cardiac fibrosis via regulating fatty acid metabolism. Redox Biol. 2023;67:102907.","journal-title":"Redox Biol"},{"key":"10678_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bbrc.2015.10.162","volume":"468","author":"T Haffar","year":"2015","unstructured":"Haffar T, B\u00e9rub\u00e9-Simard F, Bousette N. Impaired fatty acid oxidation as a cause for lipotoxicity in cardiomyocytes. Biochem Biophys Res Commun. 2015;468:73\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"10678_CR25","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cmet.2019.01.005","volume":"29","author":"M Nakamura","year":"2019","unstructured":"Nakamura M, Liu T, Husain S, Zhai P, Warren JS, Hsu C-P, Matsuda T, Phiel CJ, Cox JE, Tian B, Li H, Sadoshima J. Glycogen synthase kinase-3\u03b1 promotes fatty acid uptake and lipotoxic cardiomyopathy. Cell Metab. 2019;29:1119-1134.e12.","journal-title":"Cell Metab"},{"key":"10678_CR26","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.bbalip.2016.02.016","volume":"1861","author":"K D\u2019Souza","year":"2016","unstructured":"D\u2019Souza K, Nzirorera C, Kienesberger PC. Lipid metabolism and signaling in cardiac lipotoxicity. Biochim Biophys Acta. 2016;1861:1513\u201324.","journal-title":"Biochim Biophys Acta"},{"key":"10678_CR27","doi-asserted-by":"publisher","first-page":"771940","DOI":"10.3389\/fphar.2021.771940","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Fu Y, Jiang T, Liu B, Sun H, Zhang Y, Fan B, Li X, Qin X, Zheng Q. Enhancing fatty acids oxidation via L-carnitine attenuates obesity-related atrial fibrillation and structural remodeling by activating AMPK signaling and alleviating cardiac lipotoxicity. Front Pharmacol. 2021;12:771940.","journal-title":"Front Pharmacol"},{"key":"10678_CR28","doi-asserted-by":"publisher","first-page":"L215","DOI":"10.1152\/ajplung.00189.2024","volume":"328","author":"KWD Shin","year":"2025","unstructured":"Shin KWD, Atalay MV, Cetin-Atalay R, O\u2019Leary EM, Glass ME, Szafran JCH, Woods PS, Meliton AY, Shamaa OR, Tian Y, Mutlu GM, Hamanaka RB. mTOR signaling regulates multiple metabolic pathways in human lung fibroblasts after TGF-\u03b2 and in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2025;328:L215-28.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10678_CR29","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s00726-021-02996-8","volume":"53","author":"RB Hamanaka","year":"2021","unstructured":"Hamanaka RB, Mutlu GM. The role of metabolic reprogramming and de novo amino acid synthesis in collagen protein production by myofibroblasts: implications for organ fibrosis and cancer. Amino Acids. 2021;53:1851\u201362.","journal-title":"Amino Acids"},{"key":"10678_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.719922","volume":"11","author":"EJ Kay","year":"2021","unstructured":"Kay EJ, Koulouras G, Zanivan S. Regulation of extracellular matrix production in activated fibroblasts: roles of amino acid metabolism in collagen synthesis. Front Oncol. 2021;11: 719922.","journal-title":"Front Oncol"},{"key":"10678_CR31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1165\/rcmb.2019-0008OC","volume":"61","author":"RB Hamanaka","year":"2019","unstructured":"Hamanaka RB, O\u2019Leary EM, Witt LJ, Tian Y, G\u00f6kalp GA, Meliton AY, Dulin NO, Mutlu GM. Glutamine metabolism is required for collagen protein synthesis in lung fibroblasts. Am J Respir Cell Mol Biol. 2019;61:597\u2013606.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10678_CR32","doi-asserted-by":"publisher","first-page":"6331","DOI":"10.1111\/febs.15693","volume":"288","author":"RB Hamanaka","year":"2021","unstructured":"Hamanaka RB, Mutlu GM. Metabolic requirements of pulmonary fibrosis: role of fibroblast metabolism. FEBS J. 2021;288:6331\u201352.","journal-title":"FEBS J"},{"key":"10678_CR33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.bbrc.2016.05.097","volume":"475","author":"M Nagao","year":"2016","unstructured":"Nagao M, Toh R, Irino Y, Mori T, Nakajima H, Hara T, Honjo T, Satomi-Kobayashi S, Shinke T, Tanaka H, Ishida T, Hirata K-I. \u03b2-Hydroxybutyrate elevation as a compensatory response against oxidative stress in cardiomyocytes. Biochem Biophys Res Commun. 2016;475:322\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"10678_CR34","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/CIRCRESAHA.123.321872","volume":"132","author":"TR Matsuura","year":"2023","unstructured":"Matsuura TR, Puchalska P, Crawford PA, Kelly DP. Ketones and the heart: metabolic principles and therapeutic implications. Circ Res. 2023;132:882\u201398.","journal-title":"Circ Res"},{"key":"10678_CR35","doi-asserted-by":"publisher","first-page":"5512322","DOI":"10.1155\/2021\/5512322","volume":"2021","author":"J Tao","year":"2021","unstructured":"Tao J, Chen H, Wang Y-J, Qiu J-X, Meng Q-Q, Zou R-J, Li L, Huang J-G, Zhao Z-K, Huang Y-L, Zhang H-F, Zheng J-M. Ketogenic diet suppressed T-regulatory cells and promoted cardiac fibrosis via reducing mitochondria-associated membranes and inhibiting mitochondrial function. Oxid Med Cell Longev. 2021;2021:5512322.","journal-title":"Oxid Med Cell Longev"},{"key":"10678_CR36","doi-asserted-by":"publisher","first-page":"C1416","DOI":"10.1152\/ajpcell.00241.2024","volume":"327","author":"K Maduray","year":"2024","unstructured":"Maduray K, Zhong J. Emerging roles of ketone bodies in cardiac fibrosis. Am J Physiol Cell Physiol. 2024;327:C1416-32.","journal-title":"Am J Physiol Cell Physiol"},{"key":"10678_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/ijms25010315","volume":"25","author":"P Yan","year":"2023","unstructured":"Yan P, Liu J, Li Z, Wang J, Zhu Z, Wang L, Yu G. Glycolysis reprogramming in idiopathic pulmonary fibrosis: unveiling the mystery of lactate in the lung. Int J Mol Sci. 2023;25:315.","journal-title":"Int J Mol Sci"},{"key":"10678_CR38","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmet.2020.12.003","volume":"33","author":"AA Cluntun","year":"2021","unstructured":"Cluntun AA, Badolia R, Lettlova S, Parnell KM, Shankar TS, Diakos NA, Olson KA, Taleb I, Tatum SM, Berg JA, Cunningham CN, Van Ry T, Bott AJ, Krokidi AT, Fogarty S, Skedros S, Swiatek WI, Yu X, Luo B, Merx S, Navankasattusas S, Cox JE, Ducker GS, Holland WL, McKellar SH, Rutter J, Drakos SG. The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metab. 2021;33:629-648.e10.","journal-title":"Cell Metab"},{"key":"10678_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9465","volume":"9","author":"M Fan","year":"2023","unstructured":"Fan M, Yang K, Wang X, Chen L, Gill PS, Ha T, Liu L, Lewis NH, Williams DL, Li C. Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction. Sci Adv. 2023;9: eadc9465.","journal-title":"Sci Adv"},{"key":"10678_CR40","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s42255-020-00288-1","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Taufalele PV, Cochran JD, Robillard-Frayne I, Marx JM, Soto J, Rauckhorst AJ, Tayyari F, Pewa AD, Gray LR, Teesch LM, Puchalska P, Funari TR, McGlauflin R, Zimmerman K, Kutschke WJ, Cassier T, Hitchcock S, Lin K, Kato KM, Stueve JL, Haff L, Weiss RM, Cox JE, Rutter J, Taylor EB, Crawford PA, Lewandowski ED, Des Rosiers C, Abel ED. Mitochondrial pyruvate carriers are required for myocardial stress adaptation. Nat Metab. 2020;2:1248\u201364.","journal-title":"Nat Metab"},{"key":"10678_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10741-016-9531-1","volume":"21","author":"MJ Goldenthal","year":"2016","unstructured":"Goldenthal MJ. Mitochondrial involvement in myocyte death and heart failure. Heart Fail Rev. 2016;21:137\u201355.","journal-title":"Heart Fail Rev"},{"key":"10678_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.freeradbiomed.2018.09.019","volume":"129","author":"LA Kiyuna","year":"2018","unstructured":"Kiyuna LA, Albuquerque RPE, Chen C-H, Mochly-Rosen D, Ferreira JCB. Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities. Free Radic Biol Med. 2018;129:155\u201368.","journal-title":"Free Radic Biol Med"},{"key":"10678_CR43","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3390\/antiox12111941","volume":"12","author":"SK Bhullar","year":"2023","unstructured":"Bhullar SK, Dhalla NS. Status of mitochondrial oxidative phosphorylation during the development of heart failure. Antioxidants (Basel). 2023;12:1941.","journal-title":"Antioxidants (Basel)"},{"key":"10678_CR44","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.cardiores.2003.11.014","volume":"61","author":"M van Bilsen","year":"2004","unstructured":"van Bilsen M, Smeets PJH, Gilde AJ, van der Vusse GJ. Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc Res. 2004;61:218\u201326.","journal-title":"Cardiovasc Res"},{"key":"10678_CR45","doi-asserted-by":"publisher","first-page":"886393","DOI":"10.3389\/fcell.2022.886393","volume":"10","author":"KL Persad","year":"2022","unstructured":"Persad KL, Lopaschuk GD. Energy metabolism on mitochondrial maturation and its effects on cardiomyocyte cell fate. Front Cell Dev Biol. 2022;10:886393.","journal-title":"Front Cell Dev Biol"},{"key":"10678_CR46","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/FJC.0b013e3181e74a14","volume":"56","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Jaswal JS. Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J Cardiovasc Pharmacol. 2010;56:130\u201340.","journal-title":"J Cardiovasc Pharmacol"},{"key":"10678_CR47","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/cvr\/cvv105","volume":"106","author":"D Abdurrachim","year":"2015","unstructured":"Abdurrachim D, Luiken JJFP, Nicolay K, Glatz JFC, Prompers JJ, Nabben M. Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models. Cardiovasc Res. 2015;106:194\u2013205.","journal-title":"Cardiovasc Res"},{"key":"10678_CR48","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.yjmcc.2004.02.004","volume":"36","author":"B Lei","year":"2004","unstructured":"Lei B, Lionetti V, Young ME, Chandler MP, Agostino CD, Kang E, Altarejos M, Matsuo K, Hintze TH, Stanley WC, Recchia FA. Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. J Mol Cell Cardiol. 2004;36:567\u201376.","journal-title":"J Mol Cell Cardiol"},{"key":"10678_CR49","doi-asserted-by":"publisher","first-page":"701745","DOI":"10.3389\/fcvm.2021.701745","volume":"8","author":"Z-T Chen","year":"2021","unstructured":"Chen Z-T, Gao Q-Y, Wu M-X, Wang M, Sun R-L, Jiang Y, Guo Q, Guo D-C, Liu C-Y, Chen S-X, Liu X, Wang J-F, Zhang H-F, Chen Y-X. Glycolysis inhibition alleviates cardiac fibrosis after myocardial infarction by suppressing cardiac fibroblast activation. Front Cardiovasc Med. 2021;8:701745.","journal-title":"Front Cardiovasc Med"},{"key":"10678_CR50","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1096\/fj.201902155R","volume":"34","author":"CD Bhedi","year":"2020","unstructured":"Bhedi CD, Nasirova S, Toksoz D, Warburton RR, Morine KJ, Kapur NK, Galper JB, Preston IR, Hill NS, Fanburg BL, Penumatsa KC. Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling. FASEB J. 2020;34:930\u201344.","journal-title":"FASEB J"},{"issue":"Pt 3","key":"10678_CR51","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/bj2800561","volume":"280","author":"DA Harris","year":"1991","unstructured":"Harris DA, Das AM. Control of mitochondrial ATP synthesis in the heart. Biochem J. 1991;280(Pt 3):561\u201373.","journal-title":"Biochem J"},{"key":"10678_CR52","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1042\/BCJ20180617","volume":"476","author":"QG Karwi","year":"2019","unstructured":"Karwi QG, J\u00f6rg AR, Lopaschuk GD. Allosteric, transcriptional and post-translational control of mitochondrial energy metabolism. Biochem J. 2019;476:1695\u2013712.","journal-title":"Biochem J"},{"key":"10678_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14032","volume":"239","author":"A Zoccarato","year":"2023","unstructured":"Zoccarato A. Extending the cardiac metabolism toolkit: bringing extracellular flux analyses to the living cardiac tissue slice. Acta Physiol (Oxf). 2023;239: e14032.","journal-title":"Acta Physiol (Oxf)"},{"key":"10678_CR54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero E, Maack C. Metabolic remodelling in heart failure. Nat Rev Cardiol. 2018;15:457\u201370.","journal-title":"Nat Rev Cardiol"},{"key":"10678_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s10020-018-0005-x","volume":"24","author":"N Fillmore","year":"2018","unstructured":"Fillmore N, Levasseur JL, Fukushima A, Wagg CS, Wang W, Dyck JRB, Lopaschuk GD. Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction. Mol Med. 2018;24:3.","journal-title":"Mol Med"},{"key":"10678_CR56","unstructured":"Taylor M, Wallhaus TR, Degrado TR, Russell DC, Stanko P, Nickles RJ, Stone CK. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. J Nucl Med. 2001;42(1):55\u201362."},{"key":"10678_CR57","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.jacc.2006.06.078","volume":"48","author":"DP Dutka","year":"2006","unstructured":"Dutka DP, Pitt M, Pagano D, Mongillo M, Gathercole D, Bonser RS, Camici PG. Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease. J Am Coll Cardiol. 2006;48:2225\u201331.","journal-title":"J Am Coll Cardiol"},{"key":"10678_CR58","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1161\/01.CIR.94.11.2837","volume":"94","author":"MN Sack","year":"1996","unstructured":"Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 1996;94:2837\u201342.","journal-title":"Circulation"},{"key":"10678_CR59","doi-asserted-by":"publisher","first-page":"e37505","DOI":"10.1371\/journal.pone.0037505","volume":"7","author":"V Garc\u00eda-R\u00faa","year":"2012","unstructured":"Garc\u00eda-R\u00faa V, Otero MF, Lear PV, Rodr\u00edguez-Penas D, Feij\u00f3o-Band\u00edn S, Noguera-Moreno T, Calaza M, \u00c1lvarez-Barredo M, Mosquera-Leal A, Parrington J, Brugada J, Portol\u00e9s M, Rivera M, Gonz\u00e1lez-Juanatey JR, Lago F. Increased expression of fatty-acid and calcium metabolism genes in failing human heart. PLoS One. 2012;7:e37505.","journal-title":"PLoS One"},{"key":"10678_CR60","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","volume":"133","author":"H Sun","year":"2016","unstructured":"Sun H, Olson KC, Gao C, Prosdocimo DA, Zhou M, Wang Z, Jeyaraj D, Youn J-Y, Ren S, Liu Y, Rau CD, Shah S, Ilkayeva O, Gui W-J, William NS, Wynn RM, Newgard CB, Cai H, Xiao X, Chuang DT, Schulze PC, Lynch C, Jain MK, Wang Y. Catabolic defect of branched-chain amino acids promotes heart failure. Circulation. 2016;133:2038\u201349.","journal-title":"Circulation"},{"key":"10678_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1279066","volume":"10","author":"C Gao","year":"2023","unstructured":"Gao C, Hou L. Branched chain amino acids metabolism in heart failure. Front Nutr. 2023;10: 1279066.","journal-title":"Front Nutr"},{"key":"10678_CR62","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/nu8070405","volume":"8","author":"M-S Yoon","year":"2016","unstructured":"Yoon M-S. The emerging role of branched-chain amino acids in insulin resistance and metabolism. Nutrients. 2016;8:405.","journal-title":"Nutrients"},{"key":"10678_CR63","doi-asserted-by":"publisher","first-page":"H1160","DOI":"10.1152\/ajpheart.00114.2016","volume":"311","author":"W Wang","year":"2016","unstructured":"Wang W, Zhang F, Xia Y, Zhao S, Yan W, Wang H, Lee Y, Li C, Zhang L, Lian K, Gao E, Cheng H, Tao L. Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction. Am J Physiol Heart Circ Physiol. 2016;311:H1160-9.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10678_CR64","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","volume":"133","author":"G Aubert","year":"2016","unstructured":"Aubert G, Martin OJ, Horton JL, Lai L, Vega RB, Leone TC, Koves T, Gardell SJ, Kr\u00fcger M, Hoppel CL, Lewandowski ED, Crawford PA, Muoio DM, Kelly DP. The failing heart relies on ketone bodies as a fuel. Circulation. 2016;133:698\u2013705.","journal-title":"Circulation"},{"key":"10678_CR65","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/CIRCRESAHA.123.321872","volume":"132","author":"TR Matsuura","year":"2023","unstructured":"Matsuura TR, Puchalska P, Crawford PA, Kelly DP. Ketones and the heart: metabolic principles and therapeutic implications. Circ Res. 2023;132:882\u201398.","journal-title":"Circ Res"},{"key":"10678_CR66","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cardfail.2020.04.005","volume":"26","author":"QG Karwi","year":"2020","unstructured":"Karwi QG, Biswas D, Pulinilkunnil T, Lopaschuk GD. Myocardial ketones metabolism in heart failure. J Card Fail. 2020;26:998\u20131005.","journal-title":"J Card Fail"},{"key":"10678_CR67","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.3390\/ijms24043534","volume":"24","author":"AS Manolis","year":"2023","unstructured":"Manolis AS, Manolis TA, Manolis AA. Ketone bodies and cardiovascular disease: an alternate fuel source to the rescue. Int J Mol Sci. 2023;24:3534.","journal-title":"Int J Mol Sci"},{"key":"10678_CR68","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3390\/antiox12111941","volume":"12","author":"SK Bhullar","year":"2023","unstructured":"Bhullar SK, Dhalla NS. Status of mitochondrial oxidative phosphorylation during the development of heart failure. Antioxidants (Basel). 2023;12:1941.","journal-title":"Antioxidants (Basel)"},{"key":"10678_CR69","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1089\/ars.2018.7707","volume":"31","author":"I Luptak","year":"2019","unstructured":"Luptak I, Qin F, Sverdlov AL, Pimentel DR, Panagia M, Croteau D, Siwik DA, Bachschmid MM, He H, Balschi JA, Colucci WS. Energetic dysfunction is mediated by mitochondrial reactive oxygen species and precedes structural remodeling in metabolic heart disease. Antioxid Redox Signal. 2019;31:539\u201349.","journal-title":"Antioxid Redox Signal"},{"key":"10678_CR70","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.biocel.2011.08.008","volume":"43","author":"H Lemieux","year":"2011","unstructured":"Lemieux H, Semsroth S, Antretter H, H\u00f6fer D, Gnaiger E. Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart. Int J Biochem Cell Biol. 2011;43:1729\u201338.","journal-title":"Int J Biochem Cell Biol"},{"key":"10678_CR71","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1681\/ASN.2004050425","volume":"16","author":"DY Rhyu","year":"2005","unstructured":"Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh S, Lee HB. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol. 2005;16:667\u201375.","journal-title":"J Am Soc Nephrol"},{"key":"10678_CR72","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbrc.2015.01.121","volume":"460","author":"EE Strehler","year":"2015","unstructured":"Strehler EE. Plasma membrane calcium ATPases: from generic Ca(2+) sump pumps to versatile systems for fine-tuning cellular Ca(2+). Biochem Biophys Res Commun. 2015;460:26\u201333.","journal-title":"Biochem Biophys Res Commun"},{"key":"10678_CR73","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0006-3495(01)75727-X","volume":"81","author":"A Michailova","year":"2001","unstructured":"Michailova A, McCulloch A. Model study of ATP and ADP buffering, transport of Ca(2+) and Mg(2+), and regulation of ion pumps in ventricular myocyte. Biophys J. 2001;81:614\u201329.","journal-title":"Biophys J"},{"key":"10678_CR74","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1167\/iovs.17-22531","volume":"59","author":"M Irnaten","year":"2018","unstructured":"Irnaten M, Zhdanov A, Brennan D, Crotty T, Clark A, Papkovsky D, O\u2019Brien C. Activation of the NFAT-calcium signaling pathway in human lamina cribrosa cells in glaucoma. Invest Ophthalmol Vis Sci. 2018;59:831\u201342.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10678_CR75","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yjmcc.2012.11.006","volume":"54","author":"KM Herum","year":"2013","unstructured":"Herum KM, Lunde IG, Skrbic B, Florholmen G, Behmen D, Sjaastad I, Carlson CR, Gomez MF, Christensen G. Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress. J Mol Cell Cardiol. 2013;54:73\u201381.","journal-title":"J Mol Cell Cardiol"},{"key":"10678_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31366","volume":"239","author":"M Mandic","year":"2024","unstructured":"Mandic M, Paunovic V, Vucicevic L, Kosic M, Mijatovic S, Trajkovic V, Harhaji-Trajkovic L. No energy, no autophagy-Mechanisms and therapeutic implications of autophagic response energy requirements. J Cell Physiol. 2024;239: e31366.","journal-title":"J Cell Physiol"},{"key":"10678_CR77","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1038\/emboj.2011.104","volume":"30","author":"M Graef","year":"2011","unstructured":"Graef M, Nunnari J. Mitochondria regulate autophagy by conserved signalling pathways. EMBO J. 2011;30:2101\u201314.","journal-title":"EMBO J"},{"key":"10678_CR78","doi-asserted-by":"publisher","first-page":"H2726","DOI":"10.1152\/ajpheart.00376.2007","volume":"293","author":"N Mariappan","year":"2007","unstructured":"Mariappan N, Soorappan RN, Haque M, Sriramula S, Francis J. TNF-alpha-induced mitochondrial oxidative stress and cardiac dysfunction: restoration by superoxide dismutase mimetic Tempol. Am J Physiol Heart Circ Physiol. 2007;293:H2726-2737.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10678_CR79","doi-asserted-by":"publisher","first-page":"e22342","DOI":"10.1096\/fj.202200199RR","volume":"36","author":"L Jin","year":"2022","unstructured":"Jin L, Yu B, Liu G, Nie W, Wang J, Chen J, Xiao L, Xia H, Han F, Yang Y. Mitophagy induced by UMI-77 preserves mitochondrial fitness in renal tubular epithelial cells and alleviates renal fibrosis. FASEB J. 2022;36:e22342.","journal-title":"FASEB J"},{"key":"10678_CR80","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.3390\/ijms22115783","volume":"22","author":"DM Perez","year":"2021","unstructured":"Perez DM. Targeting adrenergic receptors in metabolic therapies for heart failure. Int J Mol Sci. 2021;22:5783.","journal-title":"Int J Mol Sci"},{"key":"10678_CR81","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/cells12050752","volume":"12","author":"SR Lee","year":"2023","unstructured":"Lee SR, Mukae M, Jeong KJ, Park SH, Shin HJ, Kim SW, Won YS, Kwun H-J, Baek I-J, Hong E-J. PGRMC1 ablation protects from energy-starved heart failure by promoting fatty acid\/pyruvate oxidation. Cells. 2023;12:752.","journal-title":"Cells"},{"key":"10678_CR82","doi-asserted-by":"publisher","first-page":"25427","DOI":"10.1074\/jbc.M115.646984","volume":"290","author":"K Bernard","year":"2015","unstructured":"Bernard K, Logsdon NJ, Ravi S, Xie N, Persons BP, Rangarajan S, Zmijewski JW, Mitra K, Liu G, Darley-Usmar VM, Thannickal VJ. Metabolic reprogramming is required for myofibroblast contractility and differentiation. J Biol Chem. 2015;290:25427\u201338.","journal-title":"J Biol Chem"},{"key":"10678_CR83","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1074\/jbc.RA117.000444","volume":"293","author":"K Bernard","year":"2018","unstructured":"Bernard K, Logsdon NJ, Benavides GA, Sanders Y, Zhang J, Darley-Usmar VM, Thannickal VJ. Glutaminolysis is required for transforming growth factor-\u03b21-induced myofibroblast differentiation and activation. J Biol Chem. 2018;293:1218\u201328.","journal-title":"J Biol Chem"},{"key":"10678_CR84","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27:441\u201364.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10678_CR85","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.4161\/cc.9.12.11989","volume":"9","author":"G Migneco","year":"2010","unstructured":"Migneco G, Whitaker-Menezes D, Chiavarina B, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Flomenberg N, Tsirigos A, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling. Cell Cycle. 2010;9:2412\u201322.","journal-title":"Cell Cycle"},{"key":"10678_CR86","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1042\/bj2140195","volume":"214","author":"MC Meienhofer","year":"1983","unstructured":"Meienhofer MC, Dreyfus JC, Kahn A. Induction of glycolytic enzyme synthesis in proliferating fibroblasts. Study of phosphofructokinase, glucose phosphate isomerase and pyruvate kinase. Biochem J. 1983;214:195\u2013201.","journal-title":"Biochem J"},{"key":"10678_CR87","doi-asserted-by":"publisher","first-page":"ehab724.0771","DOI":"10.1093\/eurheartj\/ehab724.0771","volume":"42","author":"JJ Ji","year":"2021","unstructured":"Ji JJ, Yao YUYU. Kallistatin\/ serpina3c inhibits fibrosis after myocardial infarction by regulating glycolytic pathway. Eur Heart J. 2021;42:ehab724.0771.","journal-title":"Eur Heart J"},{"key":"10678_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166441","volume":"1868","author":"J-J Ji","year":"2022","unstructured":"Ji J-J, Qian L-L, Zhu Y, Jiang Y, Guo J-Q, Wu Y, Yang Z-W, Yao Y-Y, Ma G-S. Kallistatin\/Serpina3c inhibits cardiac fibrosis after myocardial infarction by regulating glycolysis via Nr4a1 activation. Biochimica et Biophysica Acta (BBA). 2022;1868: 166441.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"10678_CR89","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1167\/iovs.64.13.36","volume":"64","author":"K-I Jeon","year":"2023","unstructured":"Jeon K-I, Kumar A, Callan CL, DeMagistris M, MacRae S, Nehrke K, Huxlin KR. Blocking mitochondrial pyruvate transport alters corneal myofibroblast phenotype: a new target for treating fibrosis. Invest Ophthalmol Vis Sci. 2023;64:36.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10678_CR90","doi-asserted-by":"publisher","first-page":"17914","DOI":"10.1038\/s41598-020-74919-8","volume":"10","author":"ER Smith","year":"2020","unstructured":"Smith ER, Hewitson TD. TGF-\u03b21 is a regulator of the pyruvate dehydrogenase complex in fibroblasts. Sci Rep. 2020;10:17914.","journal-title":"Sci Rep"},{"key":"10678_CR91","doi-asserted-by":"publisher","first-page":"9331","DOI":"10.7150\/thno.60385","volume":"11","author":"G Satyanarayana","year":"2021","unstructured":"Satyanarayana G, Turaga RC, Sharma M, Wang S, Mishra F, Peng G, Deng X, Yang J, Liu Z-R. Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts. Theranostics. 2021;11:9331\u201341.","journal-title":"Theranostics"},{"key":"10678_CR92","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bbalip.2016.11.003","volume":"1862","author":"M Sokolova","year":"2017","unstructured":"Sokolova M, Vinge LE, Alfsnes K, Olsen MB, Eide L, Kaasb\u00f8ll OJ, Attramadal H, Torp M-K, Fosshaug LE, Rashidi A, Lien E, Finsen AV, Sandanger \u00d8, Aukrust P, Ranheim T, Yndestad A. Palmitate promotes inflammatory responses and cellular senescence in cardiac fibroblasts. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862:234\u201345.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10678_CR93","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s12012-021-09653-2","volume":"21","author":"S Gao","year":"2021","unstructured":"Gao S, Li G, Shao Y, Wei Z, Huang S, Qi F, Jiao Y, Li Y, Zhang C, Du J. FABP5 deficiency impairs mitochondrial function and aggravates pathological cardiac remodeling and dysfunction. Cardiovasc Toxicol. 2021;21:619\u201329.","journal-title":"Cardiovasc Toxicol"},{"key":"10678_CR94","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1161\/CIRCULATIONAHA.110.971853","volume":"123","author":"J Chen","year":"2011","unstructured":"Chen J, Shearer GC, Chen Q, Healy CL, Beyer AJ, Nareddy VB, Gerdes AM, Harris WS, O\u2019Connell TD, Wang D. Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP\/protein kinase G signaling in cardiac fibroblasts. Circulation. 2011;123:584\u201393.","journal-title":"Circulation"},{"key":"10678_CR95","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/ATVBAHA.119.313286","volume":"40","author":"RP Mason","year":"2020","unstructured":"Mason RP, Libby P, Bhatt DL. Emerging mechanisms of cardiovascular protection for the omega-3 fatty acid eicosapentaenoic acid. Arterioscler Thromb Vasc Biol. 2020;40:1135\u201347.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10678_CR96","doi-asserted-by":"publisher","unstructured":"Smith ER, Wigg B, Holt S, Hewitson TD. TGF-\u03b21 modifies histone acetylation and acetyl-coenzyme A metabolism in renal myofibroblasts. Am J Physiol Renal Physiol. 2019;316:F517\u201329. https:\/\/doi.org\/10.1152\/ajprenal.00513.2018.","DOI":"10.1152\/ajprenal.00513.2018"},{"key":"10678_CR97","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.120.316443","volume":"126","author":"L Tian","year":"2020","unstructured":"Tian L, Wu D, Dasgupta A, Chen K-H, Mewburn J, Potus F, Lima PDA, Hong Z, Zhao Y-Y, Hindmarch CCT, Kutty S, Provencher S, Bonnet S, Sutendra G, Archer SL. Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in mitochondrial metabolism promotes right ventricular fibrosis. Circ Res. 2020;126:1723\u201345.","journal-title":"Circ Res"},{"key":"10678_CR98","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0014-4827(71)80049-6","volume":"65","author":"G Manner","year":"1971","unstructured":"Manner G. Cell division and collagen synthesis in cultured fibroblasts. Exp Cell Res. 1971;65:49\u201360.","journal-title":"Exp Cell Res"},{"key":"10678_CR99","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nchembio.2070","volume":"12","author":"ME Pacold","year":"2016","unstructured":"Pacold ME, Brimacombe KR, Chan SH, Rohde JM, Lewis CA, Swier LJYM, Possemato R, Chen WW, Sullivan LB, Fiske BP, Cho S, Freinkman E, Birsoy K, Abu-Remaileh M, Shaul YD, Liu CM, Zhou M, Koh MJ, Chung H, Davidson SM, Luengo A, Wang AQ, Xu X, Yasgar A, Liu L, Rai G, Westover KD, Vander Heiden MG, Shen M, Gray NS, Boxer MB, Sabatini DM. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat Chem Biol. 2016;12:452\u20138.","journal-title":"Nat Chem Biol"},{"key":"10678_CR100","doi-asserted-by":"publisher","first-page":"e103334","DOI":"10.15252\/embj.2019103334","volume":"39","author":"S Schw\u00f6rer","year":"2020","unstructured":"Schw\u00f6rer S, Berisa M, Violante S, Qin W, Zhu J, Hendrickson RC, Cross JR, Thompson CB. Proline biosynthesis is a vent for TGF\u03b2-induced mitochondrial redox stress. EMBO J. 2020;39:e103334.","journal-title":"EMBO J"},{"key":"10678_CR101","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1126\/science.abd5491","volume":"372","author":"J Zhu","year":"2021","unstructured":"Zhu J, Schw\u00f6rer S, Berisa M, Kyung YJ, Ryu KW, Yi J, Jiang X, Cross JR, Thompson CB. Mitochondrial NADP(H) generation is essential for proline biosynthesis. Science. 2021;372:968\u201372.","journal-title":"Science"},{"key":"10678_CR102","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cca.2004.09.013","volume":"139","author":"M F\u00e4hling","year":"2004","unstructured":"F\u00e4hling M, Perlewitz A, Doller A, Thiele B-J. Regulation of collagen prolyl 4-hydroxylase and matrix metalloproteinases in fibrosarcoma cells by hypoxia. Comp Biochem Physiol C Toxicol Pharmacol. 2004;139:119\u201326.","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"10678_CR103","doi-asserted-by":"publisher","first-page":"8920","DOI":"10.1096\/fj.202000564R","volume":"34","author":"M Choudhury","year":"2020","unstructured":"Choudhury M, Yin X, Schaefbauer KJ, Kang J-H, Roy B, Kottom TJ, Limper AH, Leof EB. SIRT7-mediated modulation of glutaminase 1 regulates TGF-\u03b2-induced pulmonary fibrosis. FASEB J. 2020;34:8920\u201340.","journal-title":"FASEB J"},{"key":"10678_CR104","doi-asserted-by":"publisher","first-page":"C1416","DOI":"10.1152\/ajpcell.00241.2024","volume":"327","author":"K Maduray","year":"2024","unstructured":"Maduray K, Zhong J. Emerging roles of ketone bodies in cardiac fibrosis. Am J Physiol Cell Physiol. 2024;327:C1416\u201332.","journal-title":"Am J Physiol Cell Physiol"},{"key":"10678_CR105","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12986-020-00510-7","volume":"17","author":"Y You","year":"2020","unstructured":"You Y, Guo Y, Jia P, Zhuang B, Cheng Y, Deng H, Wang X, Zhang C, Luo S, Huang B. Ketogenic diet aggravates cardiac remodeling in adult spontaneously hypertensive rats. Nutr Metab (Lond). 2020;17:91.","journal-title":"Nutr Metab (Lond)"},{"key":"10678_CR106","doi-asserted-by":"publisher","first-page":"5512322","DOI":"10.1155\/2021\/5512322","volume":"2021","author":"J Tao","year":"2021","unstructured":"Tao J, Chen H, Wang Y-J, Qiu J-X, Meng Q-Q, Zou R-J, Li L, Huang J-G, Zhao Z-K, Huang Y-L, Zhang H-F, Zheng J-M. Ketogenic diet suppressed t-regulatory cells and promoted cardiac fibrosis via reducing mitochondria-associated membranes and inhibiting mitochondrial function. Oxid Med Cell Longev. 2021;2021:5512322.","journal-title":"Oxid Med Cell Longev"},{"key":"10678_CR107","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cvr\/cvu264","volume":"105","author":"JE Cartledge","year":"2015","unstructured":"Cartledge JE, Kane C, Dias P, Tesfom M, Clarke L, Mckee B, Al Ayoubi S, Chester A, Yacoub MH, Camelliti P, Terracciano CM. Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators. Cardiovasc Res. 2015;105:260\u201370.","journal-title":"Cardiovasc Res"},{"key":"10678_CR108","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/cvr\/cvad104","volume":"119","author":"X Chen","year":"2023","unstructured":"Chen X, Li X, Wu X, Ding Y, Li Y, Zhou G, Wei Y, Chen S, Lu X, Xu J, Liu S, Li J, Cai L. Integrin beta-like 1 mediates fibroblast-cardiomyocyte crosstalk to promote cardiac fibrosis and hypertrophy. Cardiovasc Res. 2023;119:1928\u201341.","journal-title":"Cardiovasc Res"},{"key":"10678_CR109","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.yjmcc.2016.03.005","volume":"94","author":"J Pellman","year":"2016","unstructured":"Pellman J, Zhang J, Sheikh F. Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: mechanisms and model systems. J Mol Cell Cardiol. 2016;94:22\u201331.","journal-title":"J Mol Cell Cardiol"},{"key":"10678_CR110","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.4161\/cc.21384","volume":"11","author":"C Guido","year":"2012","unstructured":"Guido C, Whitaker-Menezes D, Capparelli C, Balliet R, Lin Z, Pestell RG, Howell A, Aquila S, And\u00f2 S, Martinez-Outschoorn U, Sotgia F, Lisanti MP. Metabolic reprogramming of cancer-associated fibroblasts by TGF-\u03b2 drives tumor growth: connecting TGF-\u03b2 signaling with \u2018Warburg-like\u2019 cancer metabolism and L-lactate production. Cell Cycle. 2012;11:3019\u201335.","journal-title":"Cell Cycle"},{"key":"10678_CR111","doi-asserted-by":"publisher","first-page":"10072","DOI":"10.3390\/ijms221810072","volume":"22","author":"E Dzia\u0142o","year":"2021","unstructured":"Dzia\u0142o E, Czepiel M, Tkacz K, Siedlar M, Kania G, B\u0142yszczuk P. WNT\/\u03b2-catenin signaling promotes TGF-\u03b2-mediated activation of human cardiac fibroblasts by enhancing IL-11 production. Int J Mol Sci. 2021;22:10072.","journal-title":"Int J Mol Sci"},{"key":"10678_CR112","first-page":"27","volume":"6","author":"NA Turner","year":"2019","unstructured":"Turner NA, Blythe NM. Cardiac fibroblast p38 MAPK: a critical regulator of myocardial remodeling. J Cardiovasc Dev Dis. 2019;6:27.","journal-title":"J Cardiovasc Dev Dis"},{"key":"10678_CR113","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ejphar.2016.07.053","volume":"789","author":"J Hu","year":"2016","unstructured":"Hu J, Wang X, Wei S-M, Tang Y-H, Zhou Q, Huang C-X. Activin A stimulates the proliferation and differentiation of cardiac fibroblasts via the ERK1\/2 and p38-MAPK pathways. Eur J Pharmacol. 2016;789:319\u201327.","journal-title":"Eur J Pharmacol"},{"key":"10678_CR114","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/HYPERTENSIONAHA.119.14556","volume":"76","author":"DN Meijles","year":"2020","unstructured":"Meijles DN, Cull JJ, Markou T, Cooper STE, Haines ZHR, Fuller SJ, O\u2019Gara P, Sheppard MN, Harding SE, Sugden PH, Clerk A. Redox regulation of cardiac ASK1 (apoptosis signal-regulating kinase 1) controls p38-MAPK (mitogen-activated protein kinase) and orchestrates cardiac remodeling to hypertension. Hypertension. 2020;76:1208\u201318.","journal-title":"Hypertension"},{"key":"10678_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122001","author":"Z Xu","year":"2016","unstructured":"Xu Z, Sun J, Tong Q, Lin Q, Qian L, Park Y, Zheng Y. The role of ERK1\/2 in the development of diabetic cardiomyopathy. Int J Mol Sci. 2016. https:\/\/doi.org\/10.3390\/ijms17122001.","journal-title":"Int J Mol Sci"},{"key":"10678_CR116","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F Fontana","year":"2024","unstructured":"Fontana F, Giannitti G, Marchesi S, Limonta P. The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer. Int J Biol Sci. 2024;20:3113\u201325.","journal-title":"Int J Biol Sci"},{"key":"10678_CR117","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41374-020-0404-9","volume":"100","author":"X Hu","year":"2020","unstructured":"Hu X, Xu Q, Wan H, Hu Y, Xing S, Yang H, Gao Y, He Z. PI3K-Akt-mTOR\/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis. Lab Invest. 2020;100:801\u201311.","journal-title":"Lab Invest"},{"key":"10678_CR118","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/wrr.13067","volume":"31","author":"Q Wang","year":"2023","unstructured":"Wang Q, Yang X, Ma J, Xie X, Sun Y, Chang X, Bi H, Xue H, Qin Z. PI3K\/AKT pathway promotes keloid fibroblasts proliferation by enhancing glycolysis under hypoxia. Wound Repair Regen. 2023;31:139\u201355.","journal-title":"Wound Repair Regen"},{"key":"10678_CR119","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10741-018-9759-z","volume":"24","author":"H Haybar","year":"2019","unstructured":"Haybar H, Khodadi E, Shahrabi S. Wnt\/\u03b2-catenin in ischemic myocardium: interactions and signaling pathways as a therapeutic target. Heart Fail Rev. 2019;24:411\u20139.","journal-title":"Heart Fail Rev"},{"key":"10678_CR120","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3892\/mmr.2012.1159","volume":"7","author":"S Zhang","year":"2013","unstructured":"Zhang S, Liu X, Goldstein S, Li Y, Ge J, He B, Fei X, Wang Z, Ruiz G. Role of the JAK\/STAT signaling pathway in the pathogenesis of acute myocardial infarction in rats and its effect on NF-\u03baB expression. Mol Med Rep. 2013;7:93\u20138.","journal-title":"Mol Med Rep"},{"key":"10678_CR121","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI94753","volume":"127","author":"H Khalil","year":"2017","unstructured":"Khalil H, Kanisicak O, Prasad V, Correll RN, Fu X, Schips T, Vagnozzi RJ, Liu R, Huynh T, Lee S-J, Karch J, Molkentin JD. Fibroblast-specific TGF-\u03b2-Smad2\/3 signaling underlies cardiac fibrosis. J Clin Invest. 2017;127:3770\u201383.","journal-title":"J Clin Invest"},{"key":"10678_CR122","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/cvr\/cvae210","volume":"120","author":"I Tuleta","year":"2024","unstructured":"Tuleta I, Hanna A, Humeres C, Aguilan JT, Sidoli S, Zhu F, Frangogiannis NG. Fibroblast-specific TGF-\u03b2 signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice. Cardiovasc Res. 2024;120:2047\u201363.","journal-title":"Cardiovasc Res"},{"key":"10678_CR123","first-page":"27","volume":"6","author":"NA Turner","year":"2019","unstructured":"Turner NA, Blythe NM. Cardiac fibroblast p38 MAPK: a critical regulator of myocardial remodeling. J Cardiovasc Dev Dis. 2019;6:27.","journal-title":"J Cardiovasc Dev Dis"},{"key":"10678_CR124","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1042\/CS20070430","volume":"115","author":"AJ Muslin","year":"2008","unstructured":"Muslin AJ. MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin Sci (Lond). 2008;115:203\u201318.","journal-title":"Clin Sci (Lond)"},{"key":"10678_CR125","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.yjmcc.2016.01.001","volume":"91","author":"EP Daskalopoulos","year":"2016","unstructured":"Daskalopoulos EP, Dufeys C, Bertrand L, Beauloye C, Horman S. AMPK in cardiac fibrosis and repair: actions beyond metabolic regulation. J Mol Cell Cardiol. 2016;91:188\u2013200.","journal-title":"J Mol Cell Cardiol"},{"issue":"39","key":"10678_CR126","first-page":"213","volume":"2018","author":"Valgimigli M, Bueno H, Byrne RA, Collet J-P, Costa F, Jeppsson A, J\u00fcni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann F-J, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN, ESC Scientific Document Group, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies","year":"2017","unstructured":"Valgimigli M, Bueno H, Byrne RA, Collet J-P, Costa F, Jeppsson A, J\u00fcni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann F-J, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN, ESC Scientific Document Group, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies. ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017;2018(39):213\u201360.","journal-title":"Eur Heart J"},{"key":"10678_CR127","doi-asserted-by":"publisher","first-page":"9767","DOI":"10.1007\/s11033-022-07468-0","volume":"49","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard S, Khanbabapour Sasi A, Hussen BM, Shoorei H, Siddiq A, Taheri M, Ayatollahi SA. Interplay between PI3K\/AKT pathway and heart disorders. Mol Biol Rep. 2022;49:9767\u201381.","journal-title":"Mol Biol Rep"},{"key":"10678_CR128","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1007\/s11010-021-04219-w","volume":"476","author":"W Qin","year":"2021","unstructured":"Qin W, Cao L, Massey IY. Role of PI3K\/Akt signaling pathway in cardiac fibrosis. Mol Cell Biochem. 2021;476:4045\u201359.","journal-title":"Mol Cell Biochem"},{"key":"10678_CR129","doi-asserted-by":"publisher","unstructured":"Li Z, Zhu S, Liu Q, Wei J, Jin Y, Wang X, Zhang L. Polystyrene microplastics cause cardiac fibrosis by activating Wnt\/\u03b2-catenin signaling pathway and promoting cardiomyocyte apoptosis in rats. Environmental Pollution. 2020;265(Pt A):115025.\u00a0https:\/\/doi.org\/10.1016\/j.envpol.2020.115025.","DOI":"10.1016\/j.envpol.2020.115025"},{"key":"10678_CR130","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.metabol.2015.10.013","volume":"65","author":"H Tao","year":"2016","unstructured":"Tao H, Yang J-J, Shi K-H, Li J. Wnt signaling pathway in cardiac fibrosis: new insights and directions. Metabolism. 2016;65:30\u201340.","journal-title":"Metabolism"},{"key":"10678_CR131","doi-asserted-by":"publisher","first-page":"341","DOI":"10.18388\/abp.2018_2635","volume":"65","author":"E Dzia\u0142o","year":"2018","unstructured":"Dzia\u0142o E, Tkacz K, B\u0142yszczuk P. Crosstalk between the TGF-\u03b2 and WNT signalling pathways during cardiac fibrogenesis. Acta Biochim Pol. 2018;65:341\u20139.","journal-title":"Acta Biochim Pol"},{"key":"10678_CR132","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","volume":"108","author":"JW Gordon","year":"2011","unstructured":"Gordon JW, Shaw JA, Kirshenbaum LA. Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB. Circ Res. 2011;108:1122\u201332.","journal-title":"Circ Res"},{"key":"10678_CR133","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbrc.2018.09.065","volume":"506","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhang M-C, Wang C-T. Loss of LRRC25 accelerates pathological cardiac hypertrophy through promoting fibrosis and inflammation regulated by TGF-\u03b21. Biochem Biophys Res Commun. 2018;506:137\u201344.","journal-title":"Biochem Biophys Res Commun"},{"key":"10678_CR134","doi-asserted-by":"publisher","unstructured":"Jiang H, Yang J, Li T, Wang X, Fan Z, Ye Q, Du Y. JAK\/STAT3 signaling in cardiac fibrosis: A promising therapeutic target. Front Pharmacol. 2024;15:1336102. https:\/\/doi.org\/10.3389\/fphar.2024.1336102.","DOI":"10.3389\/fphar.2024.1336102"},{"key":"10678_CR135","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/cvr\/cvx004","volume":"113","author":"Y Chen","year":"2017","unstructured":"Chen Y, Surinkaew S, Naud P, Qi X-Y, Gillis M-A, Shi Y-F, Tardif J-C, Dobrev D, Nattel S. JAK-STAT signalling and the atrial fibrillation promoting fibrotic substrate. Cardiovasc Res. 2017;113:310\u201320.","journal-title":"Cardiovasc Res"},{"key":"10678_CR136","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3892\/ijmm.2023.5230","volume":"51","author":"X Peng","year":"2023","unstructured":"Peng X, Wang S, Chen H, Chen M. Role of the Notch1 signaling pathway in ischemic heart disease (Review). Int J Mol Med. 2023;51:27.","journal-title":"Int J Mol Med"},{"key":"10678_CR137","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.tcm.2011.11.006","volume":"20","author":"Y Li","year":"2010","unstructured":"Li Y, Hiroi Y, Liao JK. Notch signaling as an important mediator of cardiac repair and regeneration after myocardial infarction. Trends Cardiovasc Med. 2010;20:228\u201331.","journal-title":"Trends Cardiovasc Med"},{"key":"10678_CR138","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1161\/01.RES.0000086964.07404.A5","volume":"93","author":"GD Lopaschuk","year":"2003","unstructured":"Lopaschuk GD, Barr R, Thomas PD, Dyck JRB. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase. Circ Res. 2003;93:e33-37.","journal-title":"Circ Res"},{"key":"10678_CR139","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3389\/fphar.2020.01255","volume":"11","author":"H Li","year":"2020","unstructured":"Li H, Ma Z, Zhai Y, Lv C, Yuan P, Zhu F, Wei L, Li Q, Qi X. Trimetazidine ameliorates myocardial metabolic remodeling in isoproterenol-induced rats through regulating ketone body metabolism via activating AMPK and PPAR \u03b1. Front Pharmacol. 2020;11:1255.","journal-title":"Front Pharmacol"},{"key":"10678_CR140","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/cvr\/cvq181","volume":"88","author":"X Liu","year":"2010","unstructured":"Liu X, Gai Y, Liu F, Gao W, Zhang Y, Xu M, Li Z. Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway. Cardiovasc Res. 2010;88:150\u20138.","journal-title":"Cardiovasc Res"},{"key":"10678_CR141","doi-asserted-by":"publisher","first-page":"e023378","DOI":"10.1161\/JAHA.121.023378","volume":"11","author":"J Li","year":"2022","unstructured":"Li J, Qi Y, Wang J, Dai C, Chen B, Li Y. Trimetazidine alleviates postresuscitation myocardial dysfunction and improves 96-hour survival in a ventricular fibrillation rat model. J Am Heart Assoc. 2022;11:e023378.","journal-title":"J Am Heart Assoc"},{"key":"10678_CR142","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1185\/03007990903533681","volume":"26","author":"V Fonseca","year":"2010","unstructured":"Fonseca V. Effects of \u03b2-blockers on glucose and lipid metabolism. Curr Med Res Opin. 2010;26:615\u201329.","journal-title":"Curr Med Res Opin"},{"key":"10678_CR143","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0014-2999(81)90390-3","volume":"71","author":"B Ahr\u00e9n","year":"1981","unstructured":"Ahr\u00e9n B, Lundquist I. Effects of selective and non-selective beta-adrenergic agents on insulin secretion in vivo. Eur J Pharmacol. 1981;71:93\u2013104.","journal-title":"Eur J Pharmacol"},{"key":"10678_CR144","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1054\/jcaf.2002.130238","volume":"8","author":"M Podbregar","year":"2002","unstructured":"Podbregar M, Voga G. Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure. J Card Fail. 2002;8:369\u201378.","journal-title":"J Card Fail"},{"key":"10678_CR145","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/metabo10040132","volume":"10","author":"C Beltran","year":"2020","unstructured":"Beltran C, Pardo R, Bou-Teen D, Ruiz-Meana M, Villena JA, Ferreira-Gonz\u00e1lez I, Barba I. Enhancing glycolysis protects against ischemia-reperfusion injury by reducing ROS production. Metabolites. 2020;10:132.","journal-title":"Metabolites"},{"key":"10678_CR146","doi-asserted-by":"publisher","first-page":"1291450","DOI":"10.3389\/fcvm.2023.1291450","volume":"10","author":"S Su","year":"2023","unstructured":"Su S, Ji X, Li T, Teng Y, Wang B, Han X, Zhao M. The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy. Front Cardiovasc Med. 2023;10:1291450.","journal-title":"Front Cardiovasc Med"},{"key":"10678_CR147","doi-asserted-by":"publisher","first-page":"999254","DOI":"10.3389\/fcvm.2022.999254","volume":"9","author":"Y Xi","year":"2022","unstructured":"Xi Y, Chen D, Dong Z, Zhang J, Lam H, He J, Du K, Chen C, Guo J, Xiao J. Multi-omics insights into potential mechanism of SGLT2 inhibitors cardiovascular benefit in diabetic cardiomyopathy. Front Cardiovasc Med. 2022;9:999254.","journal-title":"Front Cardiovasc Med"},{"key":"10678_CR148","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094900","author":"AA Boshchenko","year":"2024","unstructured":"Boshchenko AA, Maslov LN, Mukhomedzyanov AV, Zhuravleva OA, Slidnevskaya AS, Naryzhnaya NV, Zinovieva AS, Ilinykh PA. Peptides are cardioprotective drugs of the future: the receptor and signaling mechanisms of the cardioprotective effect of glucagon-like peptide-1 receptor agonists. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25094900.","journal-title":"Int J Mol Sci"},{"key":"10678_CR149","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2337\/db08-1193","volume":"58","author":"MH Noyan-Ashraf","year":"2009","unstructured":"Noyan-Ashraf MH, Momen MA, Ban K, Sadi A-M, Zhou Y-Q, Riazi AM, Baggio LL, Henkelman RM, Husain M, Drucker DJ. GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes. 2009;58:975\u201383.","journal-title":"Diabetes"},{"key":"10678_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173318","volume":"883","author":"R-H Zheng","year":"2020","unstructured":"Zheng R-H, Zhang W-W, Ji Y-N, Bai X-J, Yan C-P, Wang J, Bai F, Zhao Z-Q. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR\/p70S6K signaling and promoting autophagy. Eur J Pharmacol. 2020;883: 173318.","journal-title":"Eur J Pharmacol"},{"key":"10678_CR151","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2119\/molmed.2014.00259","volume":"21","author":"F Yan","year":"2015","unstructured":"Yan F, Zhang G-H, Feng M, Zhang W, Zhang J, Dong W, Zhang C, Zhang Y, Chen L, Zhang M-X. Glucagon-like peptide 1 protects against hyperglycemic-induced endothelial-to-mesenchymal transition and improves myocardial dysfunction by suppressing poly(ADP-ribose) polymerase 1 activity. Mol Med. 2015;21:15\u201325.","journal-title":"Mol Med"},{"key":"10678_CR152","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.clnu.2020.05.034","volume":"40","author":"M Yuan","year":"2021","unstructured":"Yuan M, Zhang Y, Hua T, Liu X-L, Liu T, Yuan R-Y, Li G-P, Zhu Y, Zhang X. Omega-3 polyunsaturated fatty acid supplementation improves lipid metabolism and endothelial function by providing a beneficial eicosanoid-pattern in patients with acute myocardial infarction: a randomized, controlled trial. Clin Nutr. 2021;40:445\u201359.","journal-title":"Clin Nutr"},{"key":"10678_CR153","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/antiox7080099","volume":"7","author":"RB Singh","year":"2018","unstructured":"Singh RB, Fedacko J, Mojto V, Pella D. Coenzyme Q10 modulates remodeling possibly by decreasing angiotensin-converting enzyme in patients with acute coronary syndrome. Antioxidants (Basel). 2018;7:99.","journal-title":"Antioxidants (Basel)"},{"key":"10678_CR154","doi-asserted-by":"publisher","unstructured":"Kane AE, Sinclair DA. Sirtuins and NAD+ in the development and treatment of metabolic and cardiovascular diseases. Circ Res. 2018;123(7):868\u201385. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312498.","DOI":"10.1161\/CIRCRESAHA.118.312498"},{"key":"10678_CR155","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s44161-024-00502-3","volume":"3","author":"MP Lazaropoulos","year":"2024","unstructured":"Lazaropoulos MP, Gibb AA, Chapski DJ, Nair AA, Reiter AN, Roy R, Eaton DM, Bedi KC, Margulies KB, Wellen KE, Estar\u00e1s C, Vondriska TM, Elrod JW. Nuclear ATP-citrate lyase regulates chromatin-dependent activation and maintenance of the myofibroblast gene program. Nat Cardiovasc Res. 2024;3:869\u201382.","journal-title":"Nat Cardiovasc Res"},{"key":"10678_CR156","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00018-024-05516-5","volume":"81","author":"S-X Jiang","year":"2024","unstructured":"Jiang S-X, Zhou Z-Y, Tu B, Song K, Lin L-C, Liu Z-Y, Cao W, Zhao J-Y, Tao H. Epigenetic regulation of mitochondrial fission and cardiac fibrosis via sFRP3 promoter methylation. Cell Mol Life Sci. 2024;81:483.","journal-title":"Cell Mol Life Sci"},{"key":"10678_CR157","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.3390\/cells11152347","volume":"11","author":"J Shao","year":"2022","unstructured":"Shao J, Liu J, Zuo S. Roles of epigenetics in cardiac fibroblast activation and fibrosis. Cells. 2022;11:2347.","journal-title":"Cells"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10678-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-025-10678-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10678-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T16:03:32Z","timestamp":1763568212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-025-10678-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":157,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10678"],"URL":"https:\/\/doi.org\/10.1007\/s12265-025-10678-z","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}